Early detection of pancreatic cancer in people with certain pancreatic cysts
Part of Cancer clinical trials.
This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a specific type of pancreatic cyst called IPMN that is at intermediate or high risk of turning into cancer
- You must be able to have an MRI scan (no metal implants or claustrophobia that prevent it)
- You must be covered by health insurance (like social security) in France
- You must be willing and able to give written consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.
This trial uses a special ultrasound technique (Superb Microvascular Imaging) to better understand the material inside a type of pancreatic cyst called a PIMPT. It may help doctors decide if the cyst is dangerous without needing more invasive tests.
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
Hear when a new PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.